Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction.
Allen, J.G., Bourbeau, M.P., Wohlhieter, G.E., Bartberger, M.D., Michelsen, K., Hungate, R., Gadwood, R.C., Gaston, R.D., Evans, B., Mann, L.W., Matison, M.E., Schneider, S., Huang, X., Yu, D., Andrews, P.S., Reichelt, A., Long, A.M., Yakowec, P., Yang, E.Y., Lee, T.A., Oliner, J.D.(2009) J Med Chem 52: 7044-7053
- PubMed: 19856920 
- DOI: 10.1021/jm900681h
- Primary Citation of Related Structures:  
3JZK - PubMed Abstract: 
Tumor protein 53 (p53) is a critical regulator of cell cycle and apoptosis that is frequently disabled in human tumors. In many tumor types, p53 is deleted or mutated, but in others p53 is inactivated by overexpression or amplification of its negativ ...